Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.

Di Lauro, L

Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer. [electronic resource] - Tumori - 42-4 p. digital

Publication Type: Clinical Trial; Journal Article

0300-8916

10.1177/030089169508100110 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carcinoma, Renal Cell--therapy
Drug Administration Schedule
Drug Synergism
Female
Humans
Injections, Subcutaneous
Interferon alpha-2
Interferon-alpha--administration & dosage
Interleukin-2--administration & dosage
Kidney Neoplasms--therapy
Male
Middle Aged
Recombinant Proteins
Thymopentin--administration & dosage